Holen Sie sich die Stockscreener-App
8.512
1.38%
-0.178
Handel nachbörslich:
8.56
0.048
+0.56%
Schlusskurs vom Vortag:
$8.69
Offen:
$8.51
24-Stunden-Volumen:
18,289
Relative Volume:
0.37
Marktkapitalisierung:
$27.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-7.2752
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+7.80%
1M Leistung:
+22.43%
6M Leistung:
+2,137%
1J Leistung:
+1,326%
1-Tages-Spanne:
$8.50
$8.7889
1-Wochen-Bereich:
$7.9027
$9.00
52-Wochen-Spanne:
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
8.512 | 27.62M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference - The Manila Times
Key resistance and support levels for Passage Bio Inc.Entry Point & AI Driven Stock Reports - newser.com
Smart tools for monitoring Passage Bio Inc.’s price actionPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-14 01:59:31 - newser.com
Why Passage Bio Inc. stock could rally in 2025Fed Meeting & High Accuracy Swing Entry Alerts - newser.com
Passage Bio Inc. stock prediction for this weekPortfolio Risk Summary & Entry and Exit Point Strategies - newser.com
Using flow based indicators on Passage Bio Inc.Treasury Yields & Technical Pattern Based Buy Signals - newser.com
What’s next for Passage Bio Inc. stock priceEarnings Recap Summary & Daily Stock Momentum Reports - newser.com
Multi asset correlation models including Passage Bio Inc.Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com
What the charts say about Passage Bio Inc. today2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Predicting Passage Bio Inc. trend using moving averagesExit Point & Smart Investment Allocation Insights - newser.com
Passage Bio CFO sells shares worth $1,685 - MSN
How to build a custom watchlist for Passage Bio Inc.July 2025 Drop Watch & Free Weekly Watchlist of Top Performers - newser.com
Full technical analysis of Passage Bio Inc. stockWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
What analysts say about Passage Bio Inc stockTechnical Pattern Recognition & Consistently Superior Profits - earlytimes.in
Passage Bio Inc. stock daily chart insightsTake Profit & Weekly Watchlist of Top Performers - newser.com
How buybacks impact Passage Bio Inc. stock valueTrade Risk Report & AI Driven Stock Reports - newser.com
Passage Bio Inc Stock Analysis and ForecastTrend Following Strategies & Rapid Portfolio Expansion - earlytimes.in
Is it too late to sell Passage Bio Inc.Bull Run & Weekly High Momentum Picks - newser.com
Is Passage Bio Inc. stock poised for growthWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Is Passage Bio Inc. reversing from oversold territory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Passage Bio (NASDAQ:PASG) Trading Up 1.8% – Time to Buy? - Defense World
Is Passage Bio Inc a good long term investmentMACD Histogram Signals & Investment Risk Management Tips - earlytimes.in
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Passage Bio Inc-Aktie (PASG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Sep 15 '25 |
Buy |
6.99 |
11,900 |
83,175 |
623,704 |
| Lynx1 Capital Management LP | 10% Owner |
Sep 11 '25 |
Buy |
6.96 |
325 |
2,261 |
592,021 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 24 '25 |
Buy |
5.71 |
66,423 |
379,455 |
591,696 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):